Shandong First Medical University
Clinical trials sponsored by Shandong First Medical University, explained in plain language.
-
New hope for kids with rare cancer: sirolimus combo shows promise
Disease control CompletedThis study tested a new combination of drugs (sirolimus plus chemotherapy) in 32 children with recurrent or refractory yolk sac tumors, a rare type of germ cell tumor. The goal was to see if the combination could shrink tumors and improve survival. The treatment was given in cycl…
Phase: PHASE2, PHASE3 • Sponsor: Shandong First Medical University • Aim: Disease control
Last updated Jun 26, 2026 19:11 UTC
-
Old drug, new hope: thalidomide combo shows promise for kids with rare cancer
Disease control CompletedThis completed phase 2 trial tested a combination of thalidomide and three chemotherapy drugs (nab-paclitaxel, gemcitabine, epirubicin) in 20 children with relapsed or refractory yolk sac tumor, a rare germ cell cancer. The goal was to see if this new mix could shrink tumors or l…
Phase: PHASE2 • Sponsor: Shandong First Medical University • Aim: Disease control
Last updated Jun 26, 2026 17:46 UTC
-
Mapping blood flow after rectal cancer surgery: a step toward safer operations
Knowledge-focused CompletedThis study involved 89 patients with distal sigmoid or rectal cancer who underwent standard surgery with high ligation of the inferior mesenteric artery. Researchers used CT scans before and after surgery to map blood flow paths and check if their planned routes matched reality. …
Sponsor: Shandong First Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC